Dutch Biotech Micreos #Alternative to Antibiotics# Wins Ideas From Europe Finals

Food and Healthcare Press Releases Friday April 27, 2018 10:04
THE HAGUE, Netherlands--27 Apr--PRNewswire/InfoQuest

In the iconic Hall of Knights, packed with public and policymakers, Dutch biotech Micreos 'sustainable alternative to antibiotics' was chosen as Europe's most relevant innovation, at the finals of the EU's Ideas from Europe competition. Ideas from Europe is a European initiative that facilitates sustainable innovations aimed at addressing global challenges.

(Photo: https://mma.prnewswire.com/media/682961/Ideas_from_Europe_Finalists.jpg )

In the presence of Mrs. Elsbieta Bienkowska, European Commissioner Internal Market, Industry, Entrepeneurship and SMEs, and Mrs. Mona Keijzer, State Secretary Economic Affairs & Climate Policy, 12 finalists pitched their inspiring innovations to tackle global challenges, such as healthcare challenges, climate change, immigration, bullying, food waste, extinction of species and renewable energy. Public and policymakers at the Knights Hall then chose their most impactful innovation.

With Micreos' endolysin technology, for the first time it is possible to kill only the unwanted bacteria, regardless of antibiotic resistance. Contrary to existing antibiotics it leaves the beneficial bacteria - essential for our health - intact, preserving the microbiome.

Micreos CEO Mark Offerhaus: "Antibiotic-resistance is an enormous global problem. We've already been able to help over 50.000 people suffering from inflammatory skin diseases such as eczema, acne and rosacea, and wound infections caused by the Staphylococcus aureus bacteria, including the resistant MRSA, but millions can and should benefit. Patients and policymakers need to take their responsibility. There is no need to wait and there is no time to lose."

Watch Finals pitch by Micreos CEO Mark Offerhaus: https://youtu.be/J2gGTZ6Fcrs
Ideas from Europe

Ideas from Europe is a European platform aimed at promoting the development of ideas for society's major challenges. The concept behind Ideas from Europe is that the involvement of the public at large can propel relevant breakthrough innovation ( http://www.ideasfrom.eu ).

About Micreos

Micreos ( http://www.micreos.com ) develops endolysin- and phage technology that enables targeted killing of only unwanted bacteria. The company is considered the leader in this exciting new field. Micreos runs its own production and R&D centre for endolysins in Bilthoven (Human Health) and for phages ( food safety) in Wageningen. The company works together with ETH Zurich and numerous medical and technology centres, including Erasmus MC (Rotterdam), Public Health Lab Kennemerland, the Dutch Burn Centres (Beverwijk) and many others. Gladskin is a Micreos Human Health brand ( http://www.gladskin.com ).

For further information: Dirk de Meester: +31-6-46048503 - d.demeester@micreos.com
Source: Micreos

Latest Press Release

Singapore#s first clinical trial approval for T cell engineered (TCR) immunotherapy for treatment of Liver cancer

Lion TCR Pte. Ltd., a Singapore-based Biotech company receives approval from Health Sciences Authority (HSA), Singapore, for its Phase I/II multicentre clinical study of its product candidate (LioCyx(TM)) for treatment of relapsed liver cancer post-liver...

Merck Awarded Australian CRISPR Nickase Patent for Foundational Genome-Editing Technology

- Patent covers paired Cas9 nickase technology to reduce off-target effects, advance gene therapy and research - Expands company's foundational CRISPR cutting and integration IP necessary to correct genetic defects in gene therapy patients - Merck to...

Kaneka officially starts continuous manufacturing under GMP

Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Mamoru Kadokura) have installed continuous manufacturing equipment to be applied to pharmaceutical products at Kaneka Singapore Co. (Pte.) Ltd, (Headquarters: Singapore; President: Kazuhiko...

TIENS Group opens new high-tech Experience Store in Shenzhen

TIENS Group, one of leading corporations in the Healthcare industry, unveiled a new high-tech Customer Experience Store in Shenzhen. Li Jinyuan, founder and chairman of TIENS group, announced the official opening of its first store in the world on August...

Sotera Health#s Nordion completes the sale of its medical isotopes business to BWXT

- Nordion's increased focus on gamma technologies supports Sotera Health's company-wide commitment to Safeguarding Global Health(TM) Sotera Health LLC, the world's leading, fully integrated protector of global health, today announced the closing of the...

Related Topics